The Lens Pod podcast

The Lens Newsletter: May 6, 2026

6.5.2026
0:00
8:00
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Too busy to read the Lens? Listen to our weekly summary here! In this week’s episode we discuss:

  • Ophthalmic herpes showed no overall malignancy risk, though increased risk emerged in immunologically vulnerable patients.

  • Anti-vascular endothelial growth factor therapy with brolucizumab outperformed laser in visual outcomes for proliferative diabetic retinopathy at one year.

  • Vitamin B may have a protective association with glaucoma, pointing to a potential role for nutrition in eye health.

Flere episoder fra "The Lens Pod"